Home

Oric Pharmaceuticals, Inc. - Common Stock (ORIC)

9.8600
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 10th, 6:13 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Oric Pharma Stock Hits 3-Month High On Promising Results In Prostate Cancer Trialstocktwits.com
The company also announced a $125 million private placement to fund its upcoming Phase 3 trial for ORIC-944 in metastatic prostate cancer.
Via Stocktwits · May 29, 2025
Crude Oil Falls Over 1%; Best Buy Reports Downbeat Resultsbenzinga.com
Via Benzinga · May 29, 2025
Keep an eye on the top gainers and losers in Thursday's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · May 29, 2025
ORIC Pharmaceuticals Touts Positive Efficacy, Safety Data From Early-Stage Prostate Cancer Candidate, Raises Capitalbenzinga.com
ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing plans underway.
Via Benzinga · May 29, 2025
The market is filled with gapping stocks in Thursday's session.chartmill.com
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · May 29, 2025
Where ORIC Pharmaceuticals Stands With Analystsbenzinga.com
Via Benzinga · December 13, 2023
Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · May 29, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 29, 2025
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 29, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · May 28, 2025
Get insights into the top gainers and losers of Wednesday's after-hours session.chartmill.com
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · May 28, 2025
Tuesday's session: gap up and gap down stockschartmill.com
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · February 11, 2025
H&E Equipment Services, ACM Research, Robinhood And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · January 14, 2025
PriceSmart Posts Weak Earnings, Joins Roku And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 10, 2025
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.
Via MarketBeat · November 16, 2024
ORIC Stock Earnings: ORIC Pharmaceuticals Misses EPS for Q2 2024investorplace.com
ORIC stock results show that ORIC Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024
ORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024investorplace.com
ORIC stock results show that ORIC Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 6, 2024
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yetbenzinga.com
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.
Via Benzinga · April 19, 2024
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · March 21, 2024
These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Resultsbenzinga.com
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported a loss for the fourth quarter on Monday.
Via Benzinga · March 12, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via Benzinga · February 29, 2024
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursdaybenzinga.com
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.
Via Benzinga · February 29, 2024
MicroMarvel - ORIC Pharmaceutical - Fights Cancertalkmarkets.com
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers in the United States.
Via Talk Markets · February 7, 2024
Final Boarding Call: 3 Stocks Set for a Sky-High Surgeinvestorplace.com
Although the bears hate these high potential stocks, other bullish factors suggest the pessimists are due for an unpleasant surprise.
Via InvestorPlace · January 9, 2024
3 Stocks at the Forefront of Personalized Medicine Trendinvestorplace.com
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly
Via InvestorPlace · December 5, 2023